Resveratrol: A medical drug for acute pancreatitis

World Journal of Gastroenterology

Volumn 11, Issue 21, 2005, Pages 3171-3174

  Ma, Zhen Hua ^a   Ma, Qing Yong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Acute pancreatitis; Drug; Resveratrol

Indexed keywords

POLYPHENOL DERIVATIVE; RESVERATROL;

ACUTE PANCREATITIS; ANTIINFLAMMATORY ACTIVITY; BLOOD VESSEL OCCLUSION; CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG SCREENING; EVIDENCE BASED MEDICINE; HUMAN; MICROCIRCULATION; MORBIDITY; MORTALITY; NONHUMAN; REVIEW; THROMBOCYTE AGGREGATION INHIBITION;

EID: 22144490238     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i21.3171     Document Type: Review

References (58)

1. Chase CW, Barker DE, Russell WL, Burns RP. Serum amylase and lipase in the evaluation of acute abdominal pain. Am Surg 1996; 62: 1028-1033
2. Shen F, Chen SJ, Dong XJ, Zhong H, Li YT, Cheng GF. Suppression of IL-8 gene transcription by resveratrol in phorbol ester treated human monocytic cells. J Asian Nat Prod Res 2003; 5: 151-157
3. Olas B, Wachowicz B. Biological activity of resveratrol. Postepy Hig Med Dosw 2001; 55: 71-79
4. Bhat KPL, Kosmeder JW 2nd, Pezzuto JM. Biological effects of resveratrol. Antioxid Redox Signal 2001; 3: 1041-1064
5. Baolin L, Inami Y, Tanaka H, Inagaki N, Iinuma M, Nagai H. Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro. Planta Med 2004; 70: 305-309
6. Altavilla D, Famulari C, Passaniti M, Galeano M, Macri A, Seminara P, Minutoli L, Marini H, Calo M, Venuti FS, Esposito M, Squadrito F. Attenuated cerulein-induced pancreatitis in nuclear factor-kappaB-deficient mice. Lab Invest 2003; 83: 1723-1732
7. Liu HS, Pan CE, Liu QG, Yang W, Liu XM. Effect of NF-kappaB and p38 MAPK in activated monocytes/macrophages on pro-inflammatory cytokines of rats with acute pancreatitis. World J Gastroenterol 2003; 9: 2513-2518
8. Algul H, Tando Y, Schneider G, Weidenbach H, Adler G, Schmid RM. Acute experimental pancreatitis and NF-kappaB/Rel activation. Pancreatology 2002; 2: 503-509
9. Chen X, Ji B, Han B, Ernst SA, Simeone D, Logsdon CD. NF-kappaB activation in pancreas induces pancreatic and systemic inflammatory response. Gastroenterology 2002; 122: 448-457
10. Seo JY, Kim H, Seo JT, Kim KH. Oxidative stress induced cytokine production in isolated rat pancreatic acinar cells: effects of small-molecule antioxidants. Pharmacology 2002; 64: 63-70
11. Mikami Y, Takeda K, Shibuya K, Qiu-Feng H, Shimamura H, Yamauchi J, Egawa S, Sunamura M, Yagi H, Endo Y, Matsuno S. Do peritoneal macrophages play an essential role in the progression of acute pancreatitis in rats? Pancreas 2003; 27: 253-260
12. Demydov VM, Zaporozhchenko BS, Demidov SM. Changes of cytokine levels in the serum in patients with acute pancreatitis as an early symptom for diagnosis. Klin Khir 2003; 3: 29-32
13. Sakai Y, Masamune A, Satoh A, Nishihira J, Yamagiwa T, Shimosegawa T. Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. Gastroenterology 2003; 124: 725-736
14. Schmidt J, Ebeling D, Ryschich E, Werner J, Gebhard MM, Karl E. Pancreatic capillary blood flow in an improved model of necrotizing pancreatitis in the rats. J Surg Res 2002; 106: 335-341
15. Dobosz M, Hac S, Mionskowska L, Dobrowolski S, Wajda Z. Microcirculatory disturbances of the pancreas in cerulein-induced acute pancreatitis in rats with reference to L-arginine, heparin, and procaine treatment. Pharmacol Res 1997; 36: 123-128
16. Gao HK, Zhou ZG, He T, Chen YQ, Han FH, Wang C. Effects of TCMP-1 on the changes of platelet endothelial cell adhesion molecule-1 expression in acute edematous pancreatitis. Hepatobiliary Pancreat Dis Int 2004; 3: 311-315
17. Hackert T, Werner J, Gebhard MM, Klar E. Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis. Surgery 2004; 135: 131-138
18. Kaska M, Pospisilova B, Slizova D. Pathomorphological changes in microcirculation of pancreas during experimental acute pancreatitis. Hepatogastroenterology 2000; 47: 1570-1574
19. Sunamura M, Shibuya K, Yamauchi J, Matsuno S. Microcirculatory derangement and ischemia of the pancreas. Nippon Geka Gakkai Zasshi 1999; 100: 342-346
20. Schmidt J, Klar E. Etiogoly and pathophysiology of acute pancreatitis. Ther Umsch 1996; 53: 322-332
21. von Dobschuetz E, Bleiziffer O, Pahernik S, Dellian M, Hoffmann T, Messmer K. Soluble complement receptor 1 preserves endothelial barrier function and microcirculation in postischemic pancreatitis in the rat. Am J Physiol Gastrointest Liver Physiol 2004; 286: 791-796
22. Werner J, Hartwig W, Schmidt E, Gebhard MM, Herfarth C, Klar E. Reduction of local and systemic complications of acute pancreatitis by monoclonal antibody to ICAM-1. Langenbecks Arch Chir Suppl Kongressbd 1998; 115: 725-729
23. Obermaier R, Benz S, Kortmann B, Benthues A, Ansorge N, Hopt UT. Ischemia/reperfusion-induced pancreatitis in rats: a new model of complete normothermic in situ ischemia of a pancreatic tail-segment. Clin Exp Med 2001; 1: 51-59
24. Sakorafas GH, Tsiotos GG, Sarr MG. Ischemia/Reperfusion-Induced pancreatitis. Dig Surg 2000; 17: 3-14
25. Hoffmann TF, Leiderer R, Harris AG, Messmer K. Ischemia and reperfusion in pancreas. Microsc Res Tech 1997; 37: 557-571
26. Hoffmann TF, Leiderer H, Arbogast S, Messmer K. Ischemia reperfusion of the pancreas: a new in vivo model for acute pancreatitis in rats. Res Exp Med 1995; 195: 125-144
27. Sakorafas GH, Tsiotou AG. Etiology and pathogenesis of acute pancreatitis: current concepts. J Clin Gastroenterol 2000; 30: 343-356
28. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 2001; 1: 480-481
29. Pellegatta F, Bertelli AA, Staels B, Duhem C, Fulgenzi A, Ferrero ME. Different short- and long-term effects of resveratrol on nuclear factor-kappaB phosphorylation and nuclear appearance in human endothelial cells. Am J Clin Nutr 2003; 77: 1220-1228
30. Culpitt SV, Rogers DF, Fenwick PS, Shah P, De Matos C, Russell RE, Barnes PJ, Donnelly LE. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 2003; 58: 942-946
31. Zhong M, Cheng GF, Wang WJ, Guo Y, Zhu XY, Zhang JT. Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice. Phytomedicine 1999; 6: 79-84
32. Feng YH, Zou JP, Li XY. Effects of resveratrol and ethanol on production of pro-inflammatory factors from endotoxin activated murine macrophages. Acta Pharmacol Sin 2002; 23: 1002-1006
33. Hattori R, Otani H, Maulik N, Das DK. Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol Heart Circ Physiol 2002; 282: 1988-1995
34. Zou JG, Wang ZR, Huang YZ, Cao KJ, Wu JM. Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits. Int J Mol Med 2003; 11: 317-320
35. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Forstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002; 106: 1652-1658
36. Tsai SH, Lin-Shiau SY, Lin JK. Suppression of nitric oxide synthase and the down-regulation of the activation of NF-kappa B in macrophages by resveratrol. Br J Pharmacol 1999; 126: 673-680
37. Roman V, Billard C, Kern C, Ferry-Dumazet H, Izard JC, Mohammad R, Mossalayi DM, Kolb JP. Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia. Br J Haematol 2002; 117: 842-851
38. Wang Z, Huang Y, Zou J, Cao K, Xu Y, Wu JM. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int J Mol Med 2002; 9: 77-79
39. Olas B, Wachowicz B, Saluk-Juszczak J, Zielinski T. Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin. Thromb Res 2002; 107: 141-145
40. Suttnar J, Masova L, Scheiner T, Sorelova V, Dyr JE. Role of free radicals in blood platelet activation. Cas Lek Cesk 2002; 141: 47-49
41. Shigematsu S, Ishida S, Hara M, Takahashi N, Yoshimatsu H, Sakata T, Korthuis RJ. Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radic Biol Med 2003; 34: 810-817
42. Hung LM, Su MJ, Chen JK. Resveratrol protects myocardial ischemia-reperfusion injury through both no-dependent and no-independent mechanisms. Free Radic Biol Med 2004; 36: 774-781
43. de Lorgeril M, Salen P, Guiraud A, Boucher F, de Leiris J. Resveratrol and non-ethanolic components of wine in experimental cardiology. Nutr Metab Cardiovasc Dis 2003; 13: 100-103
44. Cui J, Tosaki A, Bertelli AA, Bertelli A, Maulik N, Das DK. Cardioprotection with white wine. Drugs Exp Clin Res 2002; 28: 1-10
45. Hung LM, Chen JK, Lee RS, Liang HC, Su MJ. Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart. Free Radic Biol Med 2001; 30: 877-883
46. Bradamante S, Barenghi L, Piccinini F, Bertelli AA, De Jonge R, Beemster P, De Jong JW. Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism. Eur J Pharmacol 2003; 465: 115-123
47. Pendurthi UR, Meng F, Mackman N, Rao LV. Mechanism of resveratrol-mediated suppression of tissue factor gene expression. Thromb Haemost 2002; 87: 155-162
48. DiMagno MJ, Williams JA, Hao Y, Ernst SA, Owyang C. Endothelial nitric oxide synthase is protective in the initiation of caerulein-induced acute pancreatitis in mice. Am J Physiol Gastrointest Liver Physiol 2004; 287: 80-87
49. Zhang Z, Sun J, Li F, Zhang S, Cui Y, Sun H, Liu S. Protective effect of nitric oxide on pancreas and its relation to sulfhydryl compounds and oxygen free radicals. Zhonghua Waike Zazhi 2000; 38: 928-930
50. Dobosz M, Hac S, Wajda Z. Does nitric oxide protect from microcirculatory disturbances in experimental acute pancreatitis in rats? Int J Microcirc Clin Exp 1996; 16: 221-226
51. Taubert D, Berkels R. Upregulation and activation of eNOS by resveratrol. Circulation 2003; 107: 78-79
52. Vergara M, Modolell I, Puig-Divi V, Guarner L, Malagelada JR. Acute pancreatitis as a triggering factor for thrombotic thrombocytopenic purpura. Am J Gastroenterol 1998; 93: 2215-2218
53. Wang Z, Zou J, Huang Y, Cao K, Xu Y, Wu JM. Effect of resveratrol on platelet aggregation in vivo and in vitro. Chin Med J 2002; 115: 378-380
54. Huang SS, Tsai MC, Chih CL, Hung LM, Tsai SK. Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci 2001; 69: 1057-1065
55. Slater SJ, Seiz JL, Cook AC, Stagliano BA, Buzas CJ. Inhibition of protein kinase C by resveratrol. Biochim Biophys Acta 2003; 1637: 59-69
56. Bertelli AA, Baccalini R, Battaglia E, Falchi M, Ferrero ME. Resveratrol inhibits TNF alpha-induced endothelial cell activation. Therapie 2001; 56: 613-616
57. Mitchell RM, Byrne MF, Baillie J. Pancreatitis. Lancet 2003; 361: 1447-1455
58. Yousaf M, McCallion K, Diamond T. Management of severe acute pancreatitis. Br J Surg 2003; 90: 407-420